The Valley Desk

NCT04757636 · Interventional trial

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

Overall registry status Terminated

Phase 3

Conditions Neovascular Age-related Macular Degeneration

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov